Related content

Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients

By van Hest Reinier M.   Teun van Gelder   Vulto Arnold G.   Mathot Ron A.A.  

Clinical Pharmacokinetics, Vol. 44, Iss. 10, 2005-01 ,pp. : 1083-1096

Adis International

Access to resources Recommend Favorite

Influence of Synthetic and Natural Food Dyes on Activities of CYP2A6, UGT1A6, and UGT2B7

By Kuno Nayumi   Mizutani Takaharu  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 16, 2005-08 ,pp. : 1431-1444

Taylor & Francis Ltd

Access to resources Recommend Favorite

C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation

By Baldelli Sara   Merlini Simona   Perico Norberto   Nicastri Annalisa   Cortinovis Monica   Gotti Eliana   Remuzzi Giuseppe   Cattaneo Dario  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1127-1141

Future Medicine

Access to resources Recommend Favorite

UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients

By Tian Jia-Ni   Ho Ing-Kang   Tsou Hsiao-Hui   Fang Chiu-Ping   Hsiao Chin-Fu   Chen Chia-Hui   Tan Happy Kuy-Lok   Lin Linen   Wu Chi-Shin   Su Lien-Wen   Huang Chieh-Liang   Yang Yi-Hong   Liu Ming-Lun   Chen Yu-Ting   Liu Shu Chih   Hsu Ya-Ting   Kuo Hsiang-Wei   Liu Chen Ting   Yang Yi-Ting   Chen Andrew CH   Shih Yu-Huei   Liu Yu-Li  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 879-888

Future Medicine

Access to resources Recommend Favorite

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7

By Tsoutsikos P.   Miners J.O.   Stapleton A.   Thomas A.   Sallustio B.C.   Knights K.M.  

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite